The safe and effective delivery of anticancer agents to diseased tissues is one of the
significant challenges in cancer therapy. Conventional anticancer agents are generally …

Liposomes—microscopic phospholipid bubbles with a bilayered membrane structure—have
received a lot of attention during the past 30 years as pharmaceutical carriers of great …

Because of poor engraftment and safety concerns regarding mesenchymal stem cell (MSC)
therapy, MSC-derived exosomes have emerged as an alternative cell-free therapy for …

The transfer of mitochondria between cells has recently been revealed as a spontaneous
way to protect the injured cells. However, the utilization of this natural transfer process for …

Cytotoxic chemotherapy or radiotherapy of cancer is limited by serious, sometimes life-
threatening, side effects that arise from toxicities to sensitive normal cells because the …

Currently used pharmaceutical nanocarriers, such as liposomes, micelles, nanoemulsions,
polymeric nanoparticles and many others demonstrate a broad variety of useful properties …

Cell penetrating peptides (CPPs) can deliver cell-impermeable therapeutic cargos into cells.
In particular, CPP-cargo conjugates tend to accumulate inside cells by endocytosis …

In order to avoid the toxicities associated with prescription drug use today, we have explored
novel methods for delivering drugs selectively to pathologic cells, thereby avoiding the …

The receptor for folic acid constitutes a useful target for tumor-specific drug delivery,
primarily because:(1) it is upregulated in many human cancers, including malignancies of …

Clinically efficacious medication in anticancer therapy has been successfully designed with
liposome-based nanomedicine. The liposomal formulation in cancer drug delivery can be …